KF

KTB-KORUS Fund

Asia, Kyonggi-do, South Korea, Seongnam

Description

KTB-KORUS Fund

Investor Profile

KTB-KORUS Fund has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Personal Health
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does KTB-KORUS Fund frequently co-invest with?

Mountain Group Capital
North America, Tennessee, United States, Nashville
Co-Investments: 1
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 2
LabCorp
North America, North Carolina, United States, Burlington
Co-Investments: 2
SH
North America, Michigan, United States, Grand Rapids
Co-Investments: 1
MV
North America, Tennessee, United States, Nashville
Co-Investments: 1
180 Degree Capital
North America, New Jersey, United States, Montclair
Co-Investments: 2
DEFTA Partners
North America, California, United States, San Francisco
Co-Investments: 2
Syno Capital
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by KTB-KORUS Fund?

ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series UnknownJun 27, 2017
Amount Raised: $20,000,000
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series ADec 12, 2015
Amount Raised: $12,500,000